Disclaimer
This website (“Website”) is the property of Greenwich LifeSciences, Inc. (“Greenwich LifeSciences” or the “Company”). This Website is non-directive in nature (contains no recommendations regarding financial actions related to the Company). This Website is not to be copied or delivered to any other person or used for any other purpose without the prior consent of the Company. Visitors are advised that this Website contains no predictions regarding current or future performance or the success of outlined development programs. Although the statements in this Website have been prepared by the Company, the Company reserves the right to alter and revise the assessments contained in this Website in the future should new information become available.
Without limiting the foregoing, this Website is not an offer to sell any securities of the Company and is not to be used in connection with any offer to sell or any inquiry about or evaluation of any securities of the Company. Any such sale, or opportunity, will be subject to appropriate documentation and due diligence. The information contained herein is based on sources, which the Company believes to be reliable, but the Company has not independently verified such information and the Company does not guarantee the accuracy or completeness of such information. Although every effort has been made to assure the accuracy of the statements on this Website, the Company makes no representation or warranty as to the accuracy or completeness of the statements contained in this Website. Furthermore, the Company makes forward-looking statements in this Website about the Company’s plans, objectives, expectations, and intentions. In some cases you can identify these forward-looking statements by terms such as “anticipate,” “plan,” “expect,” “believe,” or the negative of those terms or other similar expressions, although not all forward-looking statements contain those words. By definition, such forward-looking statements involve risks, uncertainties and assumptions, and are subject to a number of such factors that could cause actual results to differ substantially from statements made, including, but not limited to: risks associated with the success of clinical trials, research and development programs, regulatory approval processes for clinical trials, competitive technologies and products, intellectual property, inception and/or continuation of corporate and other strategic partnerships and the need for additional funding or financing.